Literature DB >> 17411887

Quality assurance in radiation oncology.

Peter R Hulick1, Frank A Ascoli.   

Abstract

Assuring quality in the practice of radiation oncology has become increasingly important because of the greater complexity of treatments and the advancing knowledge of the diseases that are treated. Increased public attention to errors in medicine, the increasing use of new imaging modalities to plan therapy, the availability of new therapeutic techniques such as intensity-modulated radiation therapy, and greater dependence on information technology have increased the need for intense quality assurance (QA) in the specialty. The process of QA and the resources available to radiation oncology staff members are described.

Mesh:

Year:  2005        PMID: 17411887     DOI: 10.1016/j.jacr.2005.02.004

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  4 in total

1.  A survey of radiation treatment planning peer-review activities in a provincial radiation oncology programme: current practice and future directions.

Authors:  Michael Brundage; Sophie Foxcroft; Tom McGowan; Eric Gutierrez; Michael Sharpe; Padraig Warde
Journal:  BMJ Open       Date:  2013-07-31       Impact factor: 2.692

2.  Enhancing the role of case-oriented peer review to improve quality and safety in radiation oncology: Executive summary.

Authors:  Lawrence B Marks; Robert D Adams; Todd Pawlicki; Albert L Blumberg; David Hoopes; Michael D Brundage; Benedick A Fraass
Journal:  Pract Radiat Oncol       Date:  2013-03-16

3.  Machine learning applications in radiation oncology: Current use and needs to support clinical implementation.

Authors:  Charlotte L Brouwer; Anna M Dinkla; Liesbeth Vandewinckele; Wouter Crijns; Michaël Claessens; Dirk Verellen; Wouter van Elmpt
Journal:  Phys Imaging Radiat Oncol       Date:  2020-11-30

4.  Development, implementation, and associated challenges of a new HDR brachytherapy program.

Authors:  Daniel J Scanderbeg; Catheryn Yashar; Zoubir Ouhib; Anuja Jhingran; John Einck
Journal:  Brachytherapy       Date:  2020-09-17       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.